- Home
- ACTU vs BCV Comparison
ACTU vs BCV Comparison
Compare ACTU & BCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- BCV
- Stock Information
- Founded
- ACTU 2015
- BCV 1971
- Country
- ACTU United States
- BCV United States
- Employees
- ACTU N/A
- BCV N/A
- Industry
- ACTU
- BCV Finance/Investors Services
- Sector
- ACTU
- BCV Finance
- Exchange
- ACTU NYSE
- BCV Nasdaq
- Market Cap
- ACTU 135.0M
- BCV 110.8M
- IPO Year
- ACTU 2024
- BCV N/A
- Fundamental
- Price
- ACTU $7.26
- BCV $19.76
- Analyst Decision
- ACTU Strong Buy
- BCV
- Analyst Count
- ACTU 1
- BCV 0
- Target Price
- ACTU $20.00
- BCV N/A
- AVG Volume (30 Days)
- ACTU 170.2K
- BCV 26.3K
- Earning Date
- ACTU 09-23-2025
- BCV 01-01-0001
- Dividend Yield
- ACTU N/A
- BCV 8.13%
- EPS Growth
- ACTU N/A
- BCV N/A
- EPS
- ACTU N/A
- BCV N/A
- Revenue
- ACTU N/A
- BCV N/A
- Revenue This Year
- ACTU N/A
- BCV N/A
- Revenue Next Year
- ACTU N/A
- BCV N/A
- P/E Ratio
- ACTU N/A
- BCV N/A
- Revenue Growth
- ACTU N/A
- BCV N/A
- 52 Week Low
- ACTU $5.47
- BCV $14.09
- 52 Week High
- ACTU $11.99
- BCV $18.11
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- BCV 77.60
- Support Level
- ACTU N/A
- BCV $19.46
- Resistance Level
- ACTU N/A
- BCV $19.86
- Average True Range (ATR)
- ACTU 0.00
- BCV 0.17
- MACD
- ACTU 0.00
- BCV 0.02
- Stochastic Oscillator
- ACTU 0.00
- BCV 89.58
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About BCV Bancroft Fund Ltd.
Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.